BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 20178376)

  • 1. Molecular basis of activation of endopeptidase activity of botulinum neurotoxin type E.
    Kukreja RV; Sharma SK; Singh BR
    Biochemistry; 2010 Mar; 49(11):2510-9. PubMed ID: 20178376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative role of neurotoxin-associated proteins in the structural stability and endopeptidase activity of botulinum neurotoxin complex types A and E.
    Kukreja RV; Singh BR
    Biochemistry; 2007 Dec; 46(49):14316-24. PubMed ID: 18004882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of the endopeptidase activity of purified botulinum neurotoxins A and E by an isolated component of the native neurotoxin associated proteins.
    Sharma SK; Singh BR
    Biochemistry; 2004 Apr; 43(16):4791-8. PubMed ID: 15096048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endopeptidase activities of botulinum neurotoxin type B complex, holotoxin, and light chain.
    Wang HH; Riding S; Lindo P; Singh BR
    Appl Environ Microbiol; 2010 Oct; 76(19):6658-63. PubMed ID: 20693440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential endopeptidase activity of different forms of type A botulinum neurotoxin: A unique relationship between the size of the substrate and activity of the enzyme.
    Ambrin G; Kumar R; Singh BR
    Toxicon; 2018 Mar; 144():34-41. PubMed ID: 29309744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the disulfide cleavage induced molten globule state of type a botulinum neurotoxin in its endopeptidase activity.
    Cai S; Singh BR
    Biochemistry; 2001 Dec; 40(50):15327-33. PubMed ID: 11735415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural Compounds and Their Analogues as Potent Antidotes against the Most Poisonous Bacterial Toxin.
    Patel KB; Cai S; Adler M; Singh BK; Parmar VS; Singh BR
    Appl Environ Microbiol; 2018 Dec; 84(24):. PubMed ID: 30389764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of the endopeptidase activity of botulinum neurotoxin by its associated proteins and dithiothreitol.
    Cai S; Sarkar HK; Singh BR
    Biochemistry; 1999 May; 38(21):6903-10. PubMed ID: 10346912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologically active novel conformational state of botulinum, the most poisonous poison.
    Kukreja R; Singh B
    J Biol Chem; 2005 Nov; 280(47):39346-52. PubMed ID: 16179354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unique substrate recognition by botulinum neurotoxins serotypes A and E.
    Chen S; Barbieri JT
    J Biol Chem; 2006 Apr; 281(16):10906-11. PubMed ID: 16478727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum neurotoxin detection and differentiation by mass spectrometry.
    Barr JR; Moura H; Boyer AE; Woolfitt AR; Kalb SR; Pavlopoulos A; McWilliams LG; Schmidt JG; Martinez RA; Ashley DL
    Emerg Infect Dis; 2005 Oct; 11(10):1578-83. PubMed ID: 16318699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a fluorescence internal quenching correction factor to correct botulinum neurotoxin type A endopeptidase kinetics using SNAPtide.
    Feltrup TM; Singh BR
    Anal Chem; 2012 Dec; 84(24):10549-53. PubMed ID: 23181535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteolysis of SNAP-25 isoforms by botulinum neurotoxin types A, C, and E: domains and amino acid residues controlling the formation of enzyme-substrate complexes and cleavage.
    Vaidyanathan VV; Yoshino K; Jahnz M; Dörries C; Bade S; Nauenburg S; Niemann H; Binz T
    J Neurochem; 1999 Jan; 72(1):327-37. PubMed ID: 9886085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel role of C-terminus in introducing a functionally flexible structure critical for the biological activity of botulinum neurotoxin.
    Feltrup TM; Patel K; Kumar R; Cai S; Singh BR
    Sci Rep; 2018 Jun; 8(1):8884. PubMed ID: 29891845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of a potent cyclic peptide inhibitor with the light chain of botulinum neurotoxin A: Insights from X-ray crystallography.
    Kumaran D; Adler M; Levit M; Krebs M; Sweeney R; Swaminathan S
    Bioorg Med Chem; 2015 Nov; 23(22):7264-73. PubMed ID: 26522088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein Domain Analysis of C. botulinum Type A Neurotoxin and Its Relationship with Other Botulinum Serotypes.
    Sharma SK; Basavanna U; Shukla HD
    Toxins (Basel); 2010 Jan; 2(1):1-9. PubMed ID: 22069543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant SNAP-25 is an effective substrate for Clostridium botulinum type A toxin endopeptidase activity in vitro.
    Ekong TAN; Feavers IM; Sesardic D
    Microbiology (Reading); 1997 Oct; 143 ( Pt 10)():3337-3347. PubMed ID: 9353935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectroscopic analysis of pH-induced changes in the molecular features of type A botulinum neurotoxin light chain.
    Li L; Singh BR
    Biochemistry; 2000 May; 39(21):6466-74. PubMed ID: 10828961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of substrate recognition by botulinum neurotoxin serotype A.
    Chen S; Kim JP; Barbieri JT
    J Biol Chem; 2007 Mar; 282(13):9621-9627. PubMed ID: 17244603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A substrate sensor chip to assay the enzymatic activity of Botulinum neurotoxin A.
    Lévêque C; Ferracci G; Maulet Y; Grand-Masson C; Blanchard MP; Seagar M; El Far O
    Biosens Bioelectron; 2013 Nov; 49():276-81. PubMed ID: 23787358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.